Thermo Fisher Completes Listing of Ion PGM Dx System with FDA
Sunday, September 28, 2014
Source: GenomeWeb Daily News
The FDA registration of Thermo Fisher Scientific's Ion PGM Dx system as a Class II medical device has been finalized. The next-generation sequencing technology is used to sequence human genomic DNA based on peripheral blood specimens.